Literature DB >> 7887427

The molecular basis of HEXA mRNA deficiency caused by the most common Tay-Sachs disease mutation.

D J Boles1, R L Proia.   

Abstract

Tay-Sachs disease (TSD) is a catastrophic neurodegenerative disorder caused by mutations in the HEXA gene. The most common TSD allele worldwide contains a 4-bp insertion in exon 11 that produces a downstream premature termination codon. Despite normal transcription of this allele, HEXA mRNA is severely reduced, indicating that the HEXA transcript must be unstable. Minigenes of HEXA were constructed and expressed in mouse L cells, to investigate the relationship between the 4-bp insertion and mRNA deficiency. We conclude that the mRNA instability is caused by the premature termination codon and not by a cryptic mutation or by the 4-bp insertion directly and that degradation occurs coincident with or after splicing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887427      PMCID: PMC1801160     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 2.  Biochemistry and genetics of Tay-Sachs disease.

Authors:  R A Gravel; B L Triggs-Raine; D J Mahuran
Journal:  Can J Neurol Sci       Date:  1991-08       Impact factor: 2.104

3.  Expression of the beta-hexosaminidase alpha subunit gene with the four-base insertion of infantile Jewish Tay-Sachs disease.

Authors:  J Nishimoto; A Tanaka; E Nanba; K Suzuki
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

4.  Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.

Authors:  E E Grebner; J Tomczak
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

5.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

Authors:  A Hamosh; B C Trapnell; P L Zeitlin; C Montrose-Rafizadeh; B J Rosenstein; R G Crystal; G R Cutting
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins.

Authors:  T Henics; A Sanfridson; B J Hamilton; E Nagy; W F Rigby
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

7.  Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.

Authors:  R Rolfini; G Cabrini
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.

Authors:  R Navon; R L Proia
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.

Authors:  S Akli; J Chelly; J M Lacorte; L Poenaru; A Kahn
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

View more
  4 in total

1.  Nonsense-mediated decay of human HEXA mRNA.

Authors:  K S Rajavel; E F Neufeld
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.

Authors:  L E Maquat
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

3.  Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans.

Authors:  Jamie L Courtland; Tyler Wa Bradshaw; Greg Waitt; Erik J Soderblom; Tricia Ho; Anna Rajab; Ricardo Vancini; Il Hwan Kim; Scott H Soderling
Journal:  Elife       Date:  2021-03-22       Impact factor: 8.713

Review 4.  CRISPR Gene-Editing Models Geared Toward Therapy for Hereditary and Developmental Neurological Disorders.

Authors:  Poh Kuan Wong; Fook Choe Cheah; Saiful Effendi Syafruddin; M Aiman Mohtar; Norazrina Azmi; Pei Yuen Ng; Eng Wee Chua
Journal:  Front Pediatr       Date:  2021-03-11       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.